Sonoma Pharmaceuticals, Inc. · NASDAQ:SNOA
Sonoma Pharmaceuticals — Q1 FY2019 Earnings Presentation
8 slides from Sonoma Pharmaceuticals's earnings presentation, Aug 8, 2018
Slide 1: Sonoma Pharmaceuticals Results for the Quarter Ending 30 June 2018
NASDAQ: SNOA SONOMA PHARMACEUTICALS RESULTS FOR THE QUARTER ENDING 30 JUNE 2018 August 8, 2018
Slide 2: Agenda
NASDAQ: SNOA Page Agenda 2 Welcome / Introduction June Quarter 2018 Highlights Financial Review Q+A Jim Schutz Bob Miller
Slide 3: Forward-Looking Statement
NASDAQ: SNOA Page Forward - Looking Statement Except for historical information herein, matters set forth in this presentation are forward - looking within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including statements about the commercial a
Slide 4: Results from the Quarter Ending June 2018
NASDAQ: SNOA Page Results from the Quarter Ending 30 June 2018 4 Total Revenue = $4.4M Up 14% versus same period last year Up 20% versus the quarter ending 31 Mar 2018 U.S. dermatology revenue = $1.2M Up 1% versus same period last year Up 55% versus the quarter ending 31 Mar 2018 International reven
Slide 5: Upcoming Milestones
NASDAQ: SNOA Page Upcoming Milestones Fall 2018 Brazil – commercialization / product launches of acne and scar management product lines Second Half of 2018 US – product launch for prescription antimicrobial facial rinse as part of an acne regimen Second Half of 2018 US – product launch for Ceramax l
Slide 6: June 2018 QTR vs June 2017 QTR & March 2018 QTR
June 2018 QTR vs June 2017 QTR & March 2018 QTR 6 Quarter Ended Quarter Ended June, 2017 Quarter Ended March 31 , 2018 June 30 , 2018 Amount Variance Amount Variance Total net revenues $4,369 $3,835 $534 14 $3,656 $713 20 Product revenues $4,096 $3,603 $493 14 $3,269 $827 25 Internationa
Slide 7: Prescriptions Filled by Dermatology Product Lines
Prescriptions Filled by Dermatology Product Lines 7 $0 $198,010 $243,399 $377,433 $631,328 $807,439 $1,072,466 $814,114 $1,174,078 $1,397,080 $1,741,256 $874,709 $1,329,614 $0 $211,614 $278,145 $282,851 $439,642 $499,821 $560,899 $475,097 $827,691 $936,113 $1,045,486 $639,605 $891,664 $0 $278,952 $3
Slide 8: Prescriptions Filled by Dermatology Product Lines
Prescriptions Filled by Dermatology Product Lines 8 Total Q3 $2.3 mm Total Q4 $2.3 mm Total Q1 $1.3 mm + 40% Total Q2 $1.8 mm + 33% Total Q3 $2.3 mm + 31% Total Q4 $2.3 mm - 3% Total Q1 $3.2 mm + 39% Total Q2 $4.2 mm + 32% Total Q3 $4.6 mm + 11% Total Q4 $2.8 mm - 39% Total Q1 $3.8 mm 35% $631,328 $
Sonoma Pharmaceuticals — Q1 FY2019 Earnings Presentation on 6ix